liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Hypoxia inducible factor-1α is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response
Linköping University, Faculty of Health Sciences. Linköping University, Department of Biomedicine and Surgery, Oncology. Östergötlands Läns Landsting, Centre of Surgery and Oncology, Department of Oncology UHL.
Show others and affiliations
2006 (English)In: International Journal of Cancer, ISSN 0020-7136, Vol. 118, no 10, 2609-2616 p.Article in journal (Refereed) Published
Abstract [en]

Hypoxia is common in many solid tumours, including breast cancer. Hypoxia triggers the expression of hypoxia inducible factor-1α (HIF-1α), and HIF-1α has been associated with an impaired prognosis in breast cancer and down-regulation of the oestrogen receptor (ER), potentially affecting the treatment efficiency of antioestrogens. The role of HIF-1α regarding prognostic and treatment predictive information in breast cancer has not been established and we therefore analyzed HIF-1α using immunohistochemistry in a cohort of 377 premenopausal stage II breast cancers arranged in a tissue microarray. The patients were included in a randomized trial with either 2 years of tamoxifen or no adjuvant treatment. The tamoxifen treatment effect could be studied in subgroups of breast cancer and pure prognostic information could be scrutinized for untreated control patients. HIF-1α was scored as positive in 24% of the tumours and correlated positively to tumour size, Nottingham histological grade (NHG), Ki-67, Her2 and cyclin E expression and negatively to lymph node status, cyclin D1, ER and PR (progesterone receptor) expression. Surprisingly, there was no difference in tamoxifen response for patients with high or low HIF-1α expressing tumours. In lymph node-positive patients as well as NHG 1/2 tumours, high HIF-1α protein expression was significantly associated with an impaired recurrence-free survival (p = 0.014, 0.018). When analyzing the subgroup of NHG 1/2 tumours, a high HIF-1α expression was the only independent significant prognostic marker in multivariate analysis, including standard prognostic markers, suggesting that HIF-1α might be a useful prognostic marker in this subgroup of breast cancer, with a rather good but diverse prognosis. © 2005 Wiley-Liss, Inc.

Place, publisher, year, edition, pages
2006. Vol. 118, no 10, 2609-2616 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-37731DOI: 10.1002/ijc.21676Local ID: 38126OAI: diva2:258580
Available from: 2009-10-10 Created: 2009-10-10 Last updated: 2011-01-11

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Nordenskjöld, Bo
By organisation
Faculty of Health SciencesOncologyDepartment of Oncology UHL
In the same journal
International Journal of Cancer
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 37 hits
ReferencesLink to record
Permanent link

Direct link